Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “labelling”
Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive Bladder
ClinicalTrials.gov study NCT01054222. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label Extension and Safety Study of Talazoparib
ClinicalTrials.gov study NCT02921919. IPD Sharing: YES. Countries: 9. Publications: 0.
Climate Impact Label Design and Fast-Food Meal Selection
ClinicalTrials.gov study NCT06678178. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients
ClinicalTrials.gov study NCT02530905. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension
ClinicalTrials.gov study NCT00811018. IPD Sharing: Not stated. Countries: 16. Publications: 0.
A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism
ClinicalTrials.gov study NCT00936988. IPD Sharing: Not stated. Countries: 0. Publications: 2.
An Open-label Study to Define the Safety, Tolerability and Clinical Activity of Deutetrabenazine (AUstedo) in Adult Study Subjects With DYsTonia
ClinicalTrials.gov study NCT04173260. IPD Sharing: NO. Countries: 1. Publications: 0.
Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of
ClinicalTrials.gov study NCT01056822. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I, Open-Label, 2 Part Multicentre Study to Assess the Safety and Efficacy of Olaparib in Combination With Carboplatin in Patients With Advanced HER-2 Negative Breast Cancer
ClinicalTrials.gov study NCT02561832. IPD Sharing: Not stated. Countries: 2. Publications: 0.
An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-r
ClinicalTrials.gov study NCT00644332. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)
ClinicalTrials.gov study NCT00200447. IPD Sharing: Not stated. Countries: 0. Publications: 5.
Disposition of Carbon-14-Labeled LY2886721 ([^14C]-LY2886721) Following Oral Administration in Healthy Human Participants
ClinicalTrials.gov study NCT01367262. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria
ClinicalTrials.gov study NCT02377947. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutat
ClinicalTrials.gov study NCT01853826. IPD Sharing: YES. Countries: 11. Publications: 0.
A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00458159. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension
ClinicalTrials.gov study NCT00783094. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-label Extension to Protocol 1042-0600
ClinicalTrials.gov study NCT00512317. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease
ClinicalTrials.gov study NCT02542696. IPD Sharing: Not stated. Countries: 8. Publications: 0.
An Open-Label Safety Study of A-101 Solution
ClinicalTrials.gov study NCT02667288. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
ClinicalTrials.gov study NCT01903005. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.